BACKGROUND: Most insulin autoantibody assays for both human and animal models are in a radioassay format utilizing (125)I-insulin, but despite the radioassay format international workshops have documented difficulty in standardization between laboratories. There is thus a need for simpler assay formats that do not utilize radioactivity, yet retain the high specificity and sensitivity of radioassays. METHODS: To establish an easier enzyme-linked immunosorbent assay (ELISA) for insulin autoantibodies of non-obese diabetic (NOD) mice, we used an ELISA format, competition with unlabeled insulin, europium-avidin, and time-resolved fluorescence detection (competitive europium insulin autoantibody assay). RESULTS: The competitive europium assay of insulin autoantibodies when applied to sera from NOD mice had high sensitivity and specificity (92% sensitivity, 100% specificity) compared to our standard insulin autoantibody radioassay (72% sensitivity, 100% specificity) in analyzing blind workshop sera. It is noteworthy that though the assay has extremely high sensitivity for murine insulin autoantibodies and utilizes human insulin as target autoantigen, human sera with high levels of insulin autoantibodies are not detected. CONCLUSIONS: Our results clearly indicate that low levels of insulin autoantibodies can be detected in an ELISA-like format. Combining a europium-based ELISA with competition with fluid-phase autoantigen can be applicable to many autoantigens to achieve high specificity and sensitivity in an ELISA format.
BACKGROUND: Most insulin autoantibody assays for both human and animal models are in a radioassay format utilizing (125)I-insulin, but despite the radioassay format international workshops have documented difficulty in standardization between laboratories. There is thus a need for simpler assay formats that do not utilize radioactivity, yet retain the high specificity and sensitivity of radioassays. METHODS: To establish an easier enzyme-linked immunosorbent assay (ELISA) for insulin autoantibodies of non-obese diabetic (NOD) mice, we used an ELISA format, competition with unlabeled insulin, europium-avidin, and time-resolved fluorescence detection (competitive europium insulin autoantibody assay). RESULTS: The competitive europium assay of insulin autoantibodies when applied to sera from NOD mice had high sensitivity and specificity (92% sensitivity, 100% specificity) compared to our standard insulin autoantibody radioassay (72% sensitivity, 100% specificity) in analyzing blind workshop sera. It is noteworthy that though the assay has extremely high sensitivity for murineinsulin autoantibodies and utilizes humaninsulin as target autoantigen, human sera with high levels of insulin autoantibodies are not detected. CONCLUSIONS: Our results clearly indicate that low levels of insulin autoantibodies can be detected in an ELISA-like format. Combining a europium-based ELISA with competition with fluid-phase autoantigen can be applicable to many autoantigens to achieve high specificity and sensitivity in an ELISA format.
Authors: Liping Yu; George Eisenbarth; Ezio Bonifacio; James Thomas; Mark Atkinson; Clive Wasserfall Journal: Ann N Y Acad Sci Date: 2003-11 Impact factor: 5.691
Authors: Annette Westerlund-Karlsson; Katriina Suonpää; Matti Ankelo; Jorma Ilonen; Mikael Knip; Ari E Hinkkanen Journal: Clin Chem Date: 2003-06 Impact factor: 8.327
Authors: Li Zhang; Pilar Londono; Liping Yu; Stephen Grimes; Peter Blackburn; Peter Gottlieb; George S Eisenbarth Journal: Autoimmunity Date: 2014-05-01 Impact factor: 2.815
Authors: Isabelle Serr; Martin G Scherm; Adam M Zahm; Jonathan Schug; Victoria K Flynn; Markus Hippich; Stefanie Kälin; Maike Becker; Peter Achenbach; Alexei Nikolaev; Katharina Gerlach; Nicole Liebsch; Brigitta Loretz; Claus-Michael Lehr; Benedikt Kirchner; Melanie Spornraft; Bettina Haase; James Segars; Christoph Küper; Ralf Palmisano; Ari Waisman; Richard A Willis; Wan-Uk Kim; Benno Weigmann; Klaus H Kaestner; Anette-Gabriele Ziegler; Carolin Daniel Journal: Sci Transl Med Date: 2018-01-03 Impact factor: 17.956
Authors: Li Zhang; Tomasz Sosinowski; Aaron R Cox; Joseph Ray Cepeda; Nitin S Sekhar; Sean M Hartig; Dongmei Miao; Liping Yu; Massimo Pietropaolo; Howard W Davidson Journal: J Autoimmun Date: 2018-08-16 Impact factor: 7.094
Authors: Gaurang Jhala; Jonathan Chee; Prerak M Trivedi; Claudia Selck; Esteban N Gurzov; Kate L Graham; Helen E Thomas; Thomas Wh Kay; Balasubramanian Krishnamurthy Journal: JCI Insight Date: 2016-07-07
Authors: Liping Yu; Dongmei Miao; Laura Scrimgeour; Kelly Johnson; Marian Rewers; George S Eisenbarth Journal: Diabetes Date: 2011-11-28 Impact factor: 9.461
Authors: Gaurang Jhala; Claudia Selck; Jonathan Chee; Chun-Ting J Kwong; Evan G Pappas; Helen E Thomas; Thomas W H Kay; Balasubramanian Krishnamurthy Journal: Front Immunol Date: 2021-03-25 Impact factor: 7.561